Desai Neil's Form 4 filing
Whitehawk Therapeutics, Inc. (WHWK) · filed Sep 6, 2023
- Accession no.
- 0001209191-23-048535
- Filed
- Sep 6, 2023
- Trade date
- Sep 1-6, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $238.8K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Desai NeilCIK 0001878692 | Director, Officer (Executive Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2023 | Common Stock | SSaleDisposed | −13,889 | $5.97 | −$82,917.33 | 1,691,654 | Indirect | |
| Sep 5, 2023 | Common Stock | SSaleDisposed | −21,000 | $5.63 | −$118,230 | 1,670,654 | Indirect | |
| Sep 6, 2023 | Common Stock | SSaleDisposed | −7,111 | $5.29 | −$37,617.19 | 1,663,543 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.